A group of researchers has shown how an easy method can be applied by small labs and producers to certify compliance with Europe's polyphenols health claim.
Researchers from the University of Bologna and University of Vigo proposed a simple and cost-effective colorimetric assay using the Folin-Ciocalteu reagent to quantify phenolic content in extra virgin olive oils, in order to meet EU health claim regulations. The findings were published in the European Journal of Lipid Science and Technology, showing that this method could be efficiently used by small labs and producers to verify compliance with polyphenol health claims.
A group of researchers, including Enrico Valli, Alessandra Bendini, Giuseppe Di Lecce and Tullia Gallina Toschi from the University of Bologna, Patricia Reboredo-Rodríguez and Jesus Simal-Gándara from the University of Vigo, proposed how to use a simple analytical method to quantify the phenolic content of extra virgin olive oils in order to satisfy the requirements introduced by the EU Regulation 432/2012, which establishes a list of permitted health claims made on foods.
The team published its findings in the European Journal of Lipid Science and Technology.
“As it is well known, there are sophisticated chromatographic techniques, such as the high-performance liquid chromatography (HPLC) coupled to ultraviolet-visible or mass spectrometry detector that are used to evaluate the phenolic content of virgin olive oils,” Di Lecce explained.
“However, these systems require very expensive analytical tools and qualified technicians, while the promising results obtained in this preliminary study show that the simple and cheap colorimetric assay based on the use of the Folin-Ciocalteu (FC) reagent can be also efficiently applied to verify the compliance to the polyphenols health claim introduced by the EU Regulation.”
In order to properly convey the healthy properties of extra virgin olive oil according to the EU regulation 432/2012, it is necessary:
- to share an analytical protocol to determine the amount of hydroxytyrosol and its derivatives having a demonstrated effect of protection of blood lipids from oxidative stress;
- to check, based on this protocol, if EVOOs satisfy the EU requirements for including the specific health claim on the label.
The FC method is a well-known colorimetric assay that requires only common and cheap equipment and can be executed in any laboratory. It is commonly used for the evaluation of phenolic compounds in hydro-alcoholic extracts of EVOO.
Based on a preliminary study, the researchers proposed using hydroxytyrosol to express the results obtained with the FC method. “Tests carried out by statistical software found FC data to be fully comparable with those obtained, after hydrolysis, with the HPLC-UV method using hydroxytyrosol and tyrosol to express the results,” Enrico Valli concluded.
The promising findings, which need to be confirmed by analyzing a large number of samples to draw final conclusions, show how an easy method can be efficiently applied by small labs and producers to verify or certify the compliance to the polyphenols health claim. This is in agreement with the increasing need to propose rapid and innovative instrumental approaches for quality and authenticity of olive oils, as reported by some of the authors in a recently published review.
With €5 million of financial support, the Horizon 2020 EU OLEUM Project, recently won by a consortium coordinated by Tullia Gallina Toschi (University of Bologna), has the overall objective to assure the quality and authenticity of olive oils at a global scale.
Within the framework of this project, a specific task led by Maria Tsimidou (Aristotle University of Thessaloniki) will be devoted to the setup of a reliable protocol for the determination of phenolic compounds in virgin olive oils according to the health claim. Further study, involving many laboratories around the world, will be made possible by the OLEUM Project to innovate and harmonize the quantitative determination of olive oil polyphenols.
More articles on: chemical analysis of olive oil, EU regulation 432/2012, Horizon 2020
Sep. 9, 2025
Australian Co. Debuts New Table Olive Production Method
A new method for processing table olives in Australia is gaining attention for its potential to broaden the market. It boasts faster processing, fresh flavors, and no fermentation.
Jun. 11, 2025
EFSA Panel Rejects Some Olive Oil Polyphenol Health Claims
The panel rejected two submissions from Italy and Spain, stating that the scientific evidence fell short of the requirements.
Jun. 28, 2025
Oleacein: The Promising Phenolic Compound in Extra Virgin Olive Oil
Oleacein, a phenolic compound found in extra virgin olive oil, has antioxidant, anti-inflammatory, and potential anti-atherosclerotic properties with significant impacts on human health.
Mar. 11, 2026
Students Use Podcast to Preserve Heritage of Karaburun’s Date Olives
In the Karaburun Peninsula, students are using audio storytelling to connect climate change, rural depopulation and intergenerational knowledge to the future of the region’s distinctive date olives.
Jan. 22, 2026
Study Finds Extra Virgin Olive Oil Improves Vascular Function in Hyperlipidemia Patients
A randomized controlled trial in Greece found that extra virgin olive oil consumption improved vascular function and key cardiovascular markers in patients with hyperlipidemia.
Nov. 4, 2025
New Research Strengthens Link Between Olive Oil Polyphenols and Cardiovascular Health
A new study shows that extra virgin olive oils rich in polyphenols may provide greater cardiovascular benefits than low-phenolic varieties, improving cholesterol profiles and heart function.
Mar. 5, 2026
Food Safety Authority Seeks Public Input as EU Reassesses Xylella Fastidiosa Control Options
A sweeping assessment of studies across the EU concludes there is no field-ready cure for Xylella fastidiosa, as regulators consider updates to surveillance and containment.
Jul. 8, 2025
New Study Suggests Olive Oil May Reduce Breast Cancer Risk
New research in Italy suggests that olive oil consumption may be linked to a reduced risk of estrogen and progesterone-negative breast cancer.